| Line Item | Jun 30, 2026 | Mar 31, 2026 | Dec 31, 2025 | Sep 30, 2025 | Jun 30, 2025 | Mar 31, 2025 | Dec 31, 2024 | Sep 30, 2024 | Jun 30, 2024 | Mar 31, 2024 | Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Sales | ||||||||||||||||
| YoY growth | -37.5% | -43.1% | +77.0% | +29.0% | ||||||||||||
| Cost of sales | ||||||||||||||||
| Gross profit | ||||||||||||||||
| % of revenue | 26.1% | 22.1% | 40.7% | 38.0% | ||||||||||||
| Operating expenses: | ||||||||||||||||
| Selling, general and administrative expenses | ||||||||||||||||
| Amortization expense | ||||||||||||||||
| Transaction costs | — | — | — | |||||||||||||
| Total operating expenses | ||||||||||||||||
| % of revenue | 65.1% | 82.3% | 30.0% | 39.3% | ||||||||||||
| Operating loss | ||||||||||||||||
| % of revenue | -39.0% | -60.2% | 10.7% | -1.3% | ||||||||||||
| Other income (expense): | ||||||||||||||||
| Investment and other income | ||||||||||||||||
| Gain on sale of assets | — | — | ||||||||||||||
| Fair value remeasurement of warrant liability | — | — | ||||||||||||||
| Fair value remeasurement of contingent forward contract | — | — | ||||||||||||||
| Fair value remeasurement of contingent value rights | — | — | ||||||||||||||
| Financing fees | — | — | ||||||||||||||
| Interest expense | ||||||||||||||||
| Gain (loss) on debt extinguishment | ||||||||||||||||
| Other (expense) income, net | ||||||||||||||||
| Net loss before income taxes | ||||||||||||||||
| Net loss | ||||||||||||||||
| % of revenue | -40.9% | -56.9% | 9.6% | -2.1% | ||||||||||||
| Basic net loss per share | ||||||||||||||||
| Diluted net loss per share |